Veto Process
No veto information available
SiXSENSE
| Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|
| Nikolusiek | 262 | 37 / 35 / 9 | 178 | 69% | 4 - 4 | 27% |
| Agzim | 211 | 28 / 37 / 17 | 143 | 72% | 4 - 4 | 21% |
| Noxy | 158 | 24 / 31 / 5 | 100 | 60% | 2 - 7 | 20% |
| Mafe | 141 | 21 / 34 / 4 | 100 | 69% | 4 - 3 | 36% |
| Hipcia | 122 | 17 / 35 / 8 | 91 | 58% | 4 - 6 | 15% |
| Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|
| Nikolusiek | 262 | 37 / 35 / 9 | 178 | 69% | 4 - 4 | 27% |
| Agzim | 211 | 28 / 37 / 17 | 143 | 72% | 4 - 4 | 21% |
| Noxy | 158 | 24 / 31 / 5 | 100 | 60% | 2 - 7 | 20% |
| Mafe | 141 | 21 / 34 / 4 | 100 | 69% | 4 - 3 | 36% |
| Hipcia | 122 | 17 / 35 / 8 | 91 | 58% | 4 - 6 | 15% |
SiXSENSE
| Agent | Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|---|
|
Nikolusiek | 313 | 24 / 19 / 3 | 222 | 77% | 2 - 1 | 31% |
|
Agzim | 204 | 14 / 19 / 8 | 133 | 68% | 2 - 4 | 20% |
|
Noxy | 128 | 10 / 16 / 1 | 83 | 55% | 2 - 5 | 23% |
|
Mafe | 140 | 11 / 18 / 1 | 97 | 73% | 2 - 1 | 42% |
|
Hipcia | 107 | 8 / 18 / 4 | 82 | 55% | 1 - 2 | 14% |
| Agent | Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|---|
|
Nikolusiek | 313 | 24 / 19 / 3 | 222 | 77% | 2 - 1 | 31% |
|
Agzim | 204 | 14 / 19 / 8 | 133 | 68% | 2 - 4 | 20% |
|
Noxy | 128 | 10 / 16 / 1 | 83 | 55% | 2 - 5 | 23% |
|
Mafe | 140 | 11 / 18 / 1 | 97 | 73% | 2 - 1 | 42% |
|
Hipcia | 107 | 8 / 18 / 4 | 82 | 55% | 1 - 2 | 14% |
SiXSENSE
| Agent | Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|---|
|
Agzim | 217 | 14 / 18 / 9 | 152 | 75% | 2 - 0 | 22% |
|
Nikolusiek | 210 | 13 / 16 / 6 | 134 | 60% | 2 - 3 | 22% |
|
Noxy | 188 | 14 / 15 / 4 | 117 | 65% | 0 - 2 | 17% |
|
Mafe | 142 | 10 / 16 / 3 | 102 | 65% | 2 - 2 | 29% |
|
Hipcia | 137 | 9 / 17 / 4 | 99 | 60% | 3 - 4 | 16% |
| Agent | Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|---|
|
Agzim | 217 | 14 / 18 / 9 | 152 | 75% | 2 - 0 | 22% |
|
Nikolusiek | 210 | 13 / 16 / 6 | 134 | 60% | 2 - 3 | 22% |
|
Noxy | 188 | 14 / 15 / 4 | 117 | 65% | 0 - 2 | 17% |
|
Mafe | 142 | 10 / 16 / 3 | 102 | 65% | 2 - 2 | 29% |
|
Hipcia | 137 | 9 / 17 / 4 | 99 | 60% | 3 - 4 | 16% |